Oplx stock.

The biotechnology company had revenue of $6.60 million for the quarter, compared to analyst estimates of $4.10 million. PLx Pharma had a negative net margin of 606.91% and a negative trailing twelve-month return on equity of 291.11%. The company's revenue was up 560.0% compared to the same quarter last year.Web

Oplx stock. Things To Know About Oplx stock.

Find out all the key statistics for Protalix BioTherapeutics, Inc. (PLX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.Find the latest Protalix BioTherapeutics, Inc. (PLX) stock quote, history, news and other vital information to help you with your stock trading and investing.Today's High Today's Low 52 Week High 52 Week Low. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.

52 Week Low Date 05/12/22. Market Cap 142.764M. Shares Out 57.38M. 10 Day Average Volume 1.57M. Dividend -. Dividend Yield -. Beta 1.41. YTD % Change 81.75.Is PLX stock a good buy? Protalix BioTherapeutics Inc. (NYSE:PLX) was in 6 hedge funds' portfolios at the end of March. The all time high for this statistic is 7. PLX investors should pay ...

iPhone 14 Pro Max. If you like size and power in a smartphone, you’ll love the Apple iPhone 14 Pro Max range, now available to order in-store and online at JB. Features include a bigger battery, new chipset, updated camera setup, and subtle design changes that showcase the latest technology and connectivity.

When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.A high-level overview of Protalix BioTherapeutics, Inc. (PLX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The Protalix BioTherapeutics Inc stock price gained 0.719% on the last trading day (Friday, 17th Nov 2023), rising from $1.39 to $1.40. During the last trading day the stock fluctuated 3.28% from a day low at $1.37 to a day high of $1.42. The price has been going up and down for this period, and there has been a -24.32% loss for the last 2 …WebSince its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...

In accordance with Nasdaq Listing Rule 5810 (c) (3) (A), the Company was provided 180 calendar days, or until April 3, 2023, to regain compliance with the minimum bid requirement. On April 4, 2023 ...

A high-level overview of Protalix BioTherapeutics, Inc. (PLX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

We would like to show you a description here but the site won’t allow us. Complete Protalix BioTherapeutics Inc. stock information by Barron's. View real-time PLX stock price and news, along with industry-best analysis.Nov 29, 2023 · 9 Wall Street research analysts have issued 12-month target prices for Olaplex's shares. Their OLPX share price targets range from $2.00 to $8.00. On average, they predict the company's share price to reach $3.62 in the next twelve months. This suggests a possible upside of 64.7% from the stock's current price. Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...Olaplex Holdings, Inc. Common Stock (OLPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...A high-level overview of PLx Pharma Winddown Corp. (PLXPQ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Protalix BioTherapeutics Inc. (NYSE: PLX) was in 6 hedge funds' portfolios at the end of March. The all time high for this statistic is 7. PLX investors should pay attention to an increase in ...WebProtalix Biotherapeutics Inc (PLX) stock is trading at $2.13 as of 10:11 AM on Monday, Mar 6, a gain of $0.08, or 3.9% from the previous closing price of $2.05. The stock has traded between $2.09 and $2.15 so far today. Volume today is less active than usual.Protalix Biotherapeutics Inc (PLX) stock has risen 3.75% while the S&P 500 is up 0.29% as of 2:52 PM on Monday, Aug 17. PLX is up $0.14 from the previous closing price of $3.73 on volume of 272,865 shares. Over the past year the S&P 500 has gained 15.70% while PLX is up 52.96%. PLX lost -$1.34 per share in the over the last 12 months.Buy and Sell Used Cars Online at Cars24. Cars24.com offers home inspection to sell your car and provides 100% verified second-hand customer cars at best price with Easy Finance and RC Transfer.

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2023 Earnings Call Transcript November 6, 2023 Protalix BioTherapeutics, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.07. Operator: Good morning, ladies and gentlemen. And welcome to the Protalix Biotherapeutics Third Quarter 2023 Financial and Business Results ...Web

Corporate Profile. PLx Pharma Inc. is a commercial-stage drug delivery platform technology company focused on improving how and where active pharmaceutical ingredients (APIs) are absorbed in the gastrointestinal (GI) tract via its clinically validated and patent protected PLxGuard™ technology. PLx believes this platform has the potential to ... Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 13.00, with a high estimate of 16.00 and a low estimate of 10.00 ...Find the latest Olaplex Holdings, Inc. (OLPX) stock quote, history, news and other vital information to help you with your stock trading and investing.This means that without an appeal of the delisting notice, shares of PLXP stock will stop trading on April 13, 2023. The big news here is PLx Pharma deciding not to appeal the delisting. It makes ...This means that without an appeal of the delisting notice, shares of PLXP stock will stop trading on April 13, 2023. The big news here is PLx Pharma deciding not to appeal the delisting. It makes ...Protalix Biotherapeutics Inc (PLX) stock is lower by -0.61% while the S&P 500 is higher by 0.03% as of 3:29 PM on Tuesday, Apr 18. PLX has fallen -$0.02 from the previous closing price of $2.45 on volume of 1,744,969 shares. Over the past year the S&P 500 is lower by -5.44% while PLX is higher by 89.15%.Get Protalix Biotherapeutics Inc (PLX.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsNov 30, 2023 · See the latest Olaplex Holdings Inc stock price (OLPX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Feb 26, 2023 · At the end of day on February 24, 2023 the stock closed at $1.82, giving it a market cap near $86 million. It now seems highly likely, though not guaranteed, that pegunigalsidase alfa will be ...

View Protalix BioTherapeutics, Inc PLX investment & stock information. Get the latest Protalix BioTherapeutics, Inc PLX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Nov 29, 2023 · Protalix BioTherapeutics, Inc. (NYSE:PLX) issued its quarterly earnings data on Monday, November, 6th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.03. The company earned $10.35 million during the quarter, compared to the consensus estimate of $7.64 million. In 2022, PLX's revenue was $47.64 million, an increase of 24.22% compared to the previous year's $38.35 million. Losses were -$14.93 million, -45.88% less than in 2021. Financial Statements.42.50M. -0.54%. Get the latest Olaplex Holdings Inc (OLPX) real-time quote, historical performance, charts, and other financial information to help you make more informed …Find the latest Protalix BioTherapeutics, Inc. (PLX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Feb 26, 2023 · At the end of day on February 24, 2023 the stock closed at $1.82, giving it a market cap near $86 million. It now seems highly likely, though not guaranteed, that pegunigalsidase alfa will be ... Drugs Today. 2009;45 (12):877-890. PLx Pharma is a specialty pharmaceutical company focused on our clinically-validated and patent-protected PLxGuard™ drug delivery platform. Nov 25, 2023 · Get Protalix Biotherapeutics Inc (PLX) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Assuming growth continues to decelerate going forward, a fair value for Olaplex’s stock is probably closer to 8 USD per share, unless they can show they have …

The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Also, as of June 30, 2023, the number of amount of shares of common stock available for Protalix is worth about $6.4 million (under the 2023 ATM sale agreement).Feb 24, 2023 · What's Happening With PLX Stock Today? Protalix Biotherapeutics Inc (PLX) stock is trading at $1.86 as of 11:11 AM on Friday, Feb 24, an increase of $0.16, or 9.41% from the previous closing price of $1.70. The stock has traded between $1.69 and $1.93 so far today. Volume today is high. So far 2,222,019 shares have traded compared to average ... Feb 26, 2023 · At the end of day on February 24, 2023 the stock closed at $1.82, giving it a market cap near $86 million. It now seems highly likely, though not guaranteed, that pegunigalsidase alfa will be ... Instagram:https://instagram. eastside distillingsolarcity sharessuper stock screenerhealth insurance for diabetics type 2 NVIDIA Corporation Common Stock. $485.09 -8.46 -1.71%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers ...PLX Stock Overview. Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and … gjrtxapple watch ultra amazon Stock analysis for Olaplex Holdings Inc (OLPX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. deere and co stock Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Latest Protalix Biotherapeutics Inc Stock News. As of November 03, 2023, Protalix Biotherapeutics Inc had a $121.0 million market capitalization, putting it in the 39th percentile of companies in the Biotechnology & Medical Research industry. Currently, Protalix Biotherapeutics Inc’s price-earnings ratio is 56.4.NVIDIA Corporation Common Stock. $485.09 -8.46 -1.71%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers ...